Back to search
FDAFDA · Food and drugs·Recall number D-0615-2021

NovoLog FlexPen (insulin aspart) Injection, 100 units/mL, 3 mL Prefilled Insulin Syringe pen, Sample. Not for Resale, Rx Only, Novo Nordisk Inc., Plainsboro, NJ 08536, NDC 0169-6339-90 (Pen), NDC 0169-6339-98 (Kit)

Published April 21, 2021 · Recall initiated: March 22, 2021

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.

What to do

Voluntary: Firm initiated · Letter

Recall details

Brand
INSULIN DILUTING MEDIUM FOR NOVOLOG
Manufacturer
Novo Nordisk Inc
Distributor
Nationwide in the USA
Lot
KS6BS11, Exp 11/30/2021
Risk classification
Class I
Area (FDA)
drug
Country
United States

Sell products like this?

Recalert watches your whole catalog for recalls like this one, automatically.

Start free — no card